EMEA (Europe, Middle East and Africa) Anti-Obesity Drugs Market Report 2017

In this report, the EMEA Anti-Obesity Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Anti-Obesity Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Anti-Obesity Drugs market competition by top manufacturers/players, with Anti-Obesity Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Prescription Drugs
OTC drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Anti-Obesity Drugs for each application, including
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Anti-Obesity Drugs Market Report 2017
1 Anti-Obesity Drugs Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs
1.2.1 EMEA Anti-Obesity Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Anti-Obesity Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Prescription Drugs
1.2.4 OTC drugs
1.3 EMEA Anti-Obesity Drugs Market by Application/End Users
1.3.1 EMEA Anti-Obesity Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 6-18 Callant
1.3.3 18-30 Adult
1.3.4 30-60Middle-Aged
1.3.5 Others
1.4 EMEA Anti-Obesity Drugs Market by Region
1.4.1 EMEA Anti-Obesity Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Anti-Obesity Drugs (2012-2022)
1.5.1 EMEA Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Anti-Obesity Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Anti-Obesity Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Anti-Obesity Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Anti-Obesity Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Anti-Obesity Drugs Sale Price by Players (2012-2017)
2.2 EMEA Anti-Obesity Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Anti-Obesity Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Anti-Obesity Drugs Sale Price by Type (2012-2017)
2.3 EMEA Anti-Obesity Drugs (Volume) by Application
2.4 EMEA Anti-Obesity Drugs (Volume and Value) by Region
2.4.1 EMEA Anti-Obesity Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Anti-Obesity Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Anti-Obesity Drugs Sales Price by Region (2012-2017)

3 Europe Anti-Obesity Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Anti-Obesity Drugs Sales and Value (2012-2017)
3.1.1 Europe Anti-Obesity Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Anti-Obesity Drugs Sales and Market Share by Type
3.3 Europe Anti-Obesity Drugs Sales and Market Share by Application
3.4 Europe Anti-Obesity Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Anti-Obesity Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Anti-Obesity Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Anti-Obesity Drugs Sales and Growth Rate (2012-2017)

4 Middle East Anti-Obesity Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Anti-Obesity Drugs Sales and Value (2012-2017)
4.1.1 Middle East Anti-Obesity Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Anti-Obesity Drugs Sales and Market Share by Type
4.3 Middle East Anti-Obesity Drugs Sales and Market Share by Application
4.4 Middle East Anti-Obesity Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Anti-Obesity Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Anti-Obesity Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Anti-Obesity Drugs Sales and Growth Rate (2012-2017)

5 Africa Anti-Obesity Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Anti-Obesity Drugs Sales and Value (2012-2017)
5.1.1 Africa Anti-Obesity Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Anti-Obesity Drugs Sales and Market Share by Type
5.3 Africa Anti-Obesity Drugs Sales and Market Share by Application
5.4 Africa Anti-Obesity Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Anti-Obesity Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Anti-Obesity Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Anti-Obesity Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Anti-Obesity Drugs Sales and Growth Rate (2012-2017)

6 EMEA Anti-Obesity Drugs Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Obesity Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Anti-Obesity Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 F.Hoffmann-La Roche
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Anti-Obesity Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Anti-Obesity Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Anti-Obesity Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Anti-Obesity Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Anti-Obesity Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eisai
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Anti-Obesity Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Norgine
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Anti-Obesity Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Arena Pharmaceuticals
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Anti-Obesity Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Orexigen Therapeutics
6.12 Vivus
6.13 Alizyme
6.14 Rhythm Pharmaceuticals
6.15 Shionogi
6.16 Zafgan

7 Anti-Obesity Drugs Manufacturing Cost Analysis
7.1 Anti-Obesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Obesity Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Obesity Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Anti-Obesity Drugs Market Forecast (2017-2022)
11.1 EMEA Anti-Obesity Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Anti-Obesity Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Anti-Obesity Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Anti-Obesity Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Anti-Obesity Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Anti-Obesity Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer




List of Tables and Figures

Figure Product Picture of Anti-Obesity Drugs
Figure EMEA Anti-Obesity Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Anti-Obesity Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Prescription Drugs Product Picture
Figure OTC drugs Product Picture
Figure EMEA Anti-Obesity Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Anti-Obesity Drugs by Application in 2016
Figure 6-18 Callant Examples
Figure 18-30 Adult Examples
Figure 30-60Middle-Aged Examples
Figure Others Examples
Figure EMEA Anti-Obesity Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Anti-Obesity Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Anti-Obesity Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Anti-Obesity Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Players (2012-2017)
Figure 2016 Anti-Obesity Drugs Sales Share by Players
Figure 2017 Anti-Obesity Drugs Sales Share by Players
Figure EMEA Anti-Obesity Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Anti-Obesity Drugs Revenue Share by Players
Table 2017 EMEA Anti-Obesity Drugs Revenue Share by Players
Table EMEA Anti-Obesity Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Type (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Type in 2016
Table EMEA Anti-Obesity Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Application (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share by Application in 2016
Table EMEA Anti-Obesity Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Anti-Obesity Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Anti-Obesity Drugs by Region (2012-2017)
Figure EMEA Anti-Obesity Drugs Sales Market Share in 2016
Table EMEA Anti-Obesity Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Anti-Obesity Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Region (2012-2017)
Figure EMEA Anti-Obesity Drugs Revenue Market Share Regions in 2016
Table EMEA Anti-Obesity Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue and Growth Rate (2012-2017)
Table Europe Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Type (2012-2017)
Figure Europe Anti-Obesity Drugs Market Share by Type in 2016
Table Europe Anti-Obesity Drugs Sales (K Units) by Application (2012-2017)
Table Europe Anti-Obesity Drugs Market Share by Application (2012-2017)
Figure Europe Anti-Obesity Drugs Market Share by Application in 2016
Table Europe Anti-Obesity Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Sales Market Share by Countries in 2016
Table Europe Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure Germany Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Anti-Obesity Drugs Market Share by Type (2012-2017)
Figure Middle East Anti-Obesity Drugs Market Share by Type (2012-2017)
Table Middle East Anti-Obesity Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Anti-Obesity Drugs Market Share by Applications (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales Market Share by Application in 2016
Table Middle East Anti-Obesity Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Anti-Obesity Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Anti-Obesity Drugs Sales (K Units) by Type (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Type (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Type in 2016
Table Africa Anti-Obesity Drugs Sales (K Units) by Application (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Application (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Application (2012-2017)
Table Africa Anti-Obesity Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Sales Market Share by Countries in 2016
Table Africa Anti-Obesity Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Anti-Obesity Drugs Revenue Market Share by Countries in 2016
Figure South Africa Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Pfizer Anti-Obesity Drugs Basic Information List
Table Pfizer Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck Anti-Obesity Drugs Basic Information List
Table Merck Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table F.Hoffmann-La Roche Anti-Obesity Drugs Basic Information List
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure F.Hoffmann-La Roche Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Anti-Obesity Drugs Basic Information List
Table GlaxoSmithKline Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Anti-Obesity Drugs Basic Information List
Table AstraZeneca Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Anti-Obesity Drugs Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Anti-Obesity Drugs Basic Information List
Table Novo Nordisk Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Eisai Anti-Obesity Drugs Basic Information List
Table Eisai Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eisai Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Eisai Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Norgine Anti-Obesity Drugs Basic Information List
Table Norgine Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Norgine Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Norgine Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Norgine Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Arena Pharmaceuticals Anti-Obesity Drugs Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Sales Market Share in EMEA (2012-2017)
Figure Arena Pharmaceuticals Anti-Obesity Drugs Revenue Market Share in EMEA (2012-2017)
Table Orexigen Therapeutics Anti-Obesity Drugs Basic Information List
Table Vivus Anti-Obesity Drugs Basic Information List
Table Alizyme Anti-Obesity Drugs Basic Information List
Table Rhythm Pharmaceuticals Anti-Obesity Drugs Basic Information List
Table Shionogi Anti-Obesity Drugs Basic Information List
Table Zafgan Anti-Obesity Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2016
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure EMEA Anti-Obesity Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Anti-Obesity Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Anti-Obesity Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Anti-Obesity Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Obesity Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Anti-Obesity Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Anti-Obesity Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Anti-Obesity Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Anti-Obesity Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Anti-Obesity Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Global Anti-Neprilysin Market Research Report 2018

Published Date : May 2018

Anti-Neprilysin Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, German...

Global Anti-Transthyretin Market Research Report 2018

Published Date : May 2018

Anti-Transthyretin Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Ger...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Briquette Market 2018, Forecast to 2023

Published Date : Jun 2018

Biomass briquettes are mostly used in the developing world, where cooking fuels are not as easily available. There has been a move to the use of briquettes in the developed world, where they are used to heat industrial boilers in order to produce electricity from steam. The briquettes are cofired wi...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Blue Laser Diodes Market 2018, Forecast to 2023

Published Date : Jun 2018

Laser diodes are electrically pumped semiconductor lasers in which the gain is generated by an electrical current flowing through a p-n junction or (more frequently) a p-i-n structure. In such a heterostructure, electrons and holes can recombine, releasing the energy portions as photons. This proces...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Ultrafine Precipitated Calcium Carbonate Market 2018, Forecast to 2023

Published Date : Jun 2018

A special category of PCC is the ultrafine PCC, or as it is now more commonly known, the Nano PCC. Nano particles are those which are less than 100 nanometers or 0.1 microns in size. To help judge what this means: a human hair is between 40 to 120 microns thick. To give you an idea of how small this...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Sweet Potato Starch Market 2018, Forecast to 2023

Published Date : Jun 2018

Sweet potato starch is a type of natural starch from sweet potatoes. It is made from fresh sweet potato or dried sweet potato chips. However, fresh processing starch is the main type products because the quality of fresh sweet potato starch is better than dried sweet potato starch and it is demandin...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Plastic Waste Management Market 2018, Forecast to 2023

Published Date : Jun 2018

Plastic waste management is a collective term for various approaches and strategies used to recycle plastic materials that would otherwise be dumped into landfills, or bodies of water, or otherwise contaminate the environment. The idea behind this type of waste management is to utilize those discard...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Electronic Article Surveillance Market 2018, Forecast to 2023

Published Date : Jun 2018

Electronic article surveillance (EAS) is a technological method for preventing shoplifting from retail stores, pilferage of books from libraries or removal of properties from office buildings. Special tags are fixed to merchandise or books. These tags are removed or deactivated by the clerks when th...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Sous Vide Machine Market 2018, Forecast to 2023

Published Date : Jun 2018

Sous vide is a unique process of cooking, the food must be packaged in a vacuum sealed bag, and then cooked at a low and consistent temperature in a water bath. The process started in France and has been growing in popularity; used by chefs on "Top Chef" and "The Taste", as well as restaurants all o...

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Solar Charger Market 2018, Forecast to 2023

Published Date : Jun 2018

A solar charger employs solar energy to supply electricity to devices or charge batteries. They are generally portable. Solar chargers can charge lead acid or Ni-Cd battery banks up to 48 V and hundreds of ampere-hours (up to 4000 Ah) capacity. Such type of solar charger setups generally use an inte...

 

Select Licence :

  • Single User : $4000
  • Corporate User : $8000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.